The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrative analysis of VB10.16 and atezolizumab in advanced HPV16-positive cervical cancer: Linking biomarker insights to clinical outcomes.
 
Kristina Lindemann
Honoraria - AstraZeneca; GlaxoSmithKline; MSD
Consulting or Advisory Role - AstraZeneca; Eisai; Genmab; GlaxoSmithKline; MSD
Research Funding - GlaxoSmithKline (Inst)
 
Michal Zikan
No Relationships to Disclose
 
Frederic Forget
Travel, Accommodations, Expenses - Gilead Sciences (Inst); ipsen; Novartis; Teva
 
Hannelore Denys
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst); Teva (Inst)
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Jean-François Baurain
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi/Regeneron (Inst); Sun Pharma (Inst); Sun Pharma (Inst)
 
Lukas Rob
Speakers' Bureau - Abbott Laboratories; Covidien/Medtronic
 
Linn Woelber
Honoraria - Abbvie; AstraZeneca; Eisai Europe; Genmab/Seagen; GlaxoSmithKline; Medac; MSD; Pfizer; Regeneron; Roche; Seagen; Teva
Consulting or Advisory Role - Abbvie/Genentech; Eisai Europe; Genmab; Gilead Sciences; MSD; Pfizer; Regeneron; Roche; Seagen
Research Funding - Abbvie (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche (Inst)
 
Frederik Marmé
No Relationships to Disclose
 
Theresa Link
Honoraria - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen; Stemline Therapeutics
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Myriad Genetics; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Seagen; Stemline Therapeutics
 
Christian Dannecker
Honoraria - AstraZeneca; MSD; Roche; Stemline Therapeutics
 
Kaja Christine Graue Berg
Employment - Nykode Therapeutics
 
Roberto Oliveri
Employment - Nykode Therapeutics
Stock and Other Ownership Interests - Nykode Therapeutics
 
Milena Blaga
Employment - Nykode Therapeutics
 
Anders Rosholm
Employment - Nykode Therapeutics A/S
Travel, Accommodations, Expenses - Nykode Therapeutics A/S
 
Peter Hillemanns
Honoraria - AstraZeneca; MSD
Research Funding - Asieris Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Asieris Pharmaceuticals
 
C-02 Investigators
No Relationships to Disclose